Vertebral Compression Fracture Devices Market Overview:

Global Vertebral Compression Fracture Devices Market was valued at $748 million in 2015, and is expected to reach $1,109 million by 2022, supported by a CAGR of 5.7% during the forecast period 2014 - 2022. Vertebral compression fracture (VCF) generally occurs when the block-like part of a single bone of the spine (vertebra) is compressed due to trauma. Vertebral implants are used in the treatment of compression fractures of the spine as they stabilize the fracture and ease pain

Osteoporosis is the major cause of vertebral compression fractures, accounting for ~85% of all VCF cases. These fractures can also occur due to trauma, multiple myeloma, metastasis, and malignant bone tumors that may cause spine collapse. According to the American Academy of Orthopaedic Surgeons, ~750,000 cases of osteoporosis-related VCFs occur in the U.S. alone. In addition, more than 25% of all menopausal women are affected by VCF in the U.S.; however, approximately two-thirds of these patients do not opt for diagnosis as they consider back pain as a sign of aging and arthritis. Thus, this large undiagnosed patient base provides numerous growth opportunities for this market. VCF is more prevalent in people aged 60 or above, thus the increase in geriatric population and rise in incidence of osteoporosis and arthritis drive the market growth. Moreover, factors such as short recovery period, low risk of infection, and shorter hospital stay are expected to contribute to market growth. However, the risk of post-surgical complications, i.e., hemorrhage, vertebral posterior element fracture, nerve root irritation, and acceleration of osteoporosis; and unfavorable reimbursement scenario may hinder the market growth.

On the basis of product type, VCF devices market is bifurcated into balloon kyphoplasty and vertebroplasty. Vertebroplasty is a minimal invasive and non-surgical procedure used to treat vertebral compression fractures. Therefore, most of the surgeries are performed in ambulatory surgical centers and recovery period gets reduced to 6-12 weeks. In kyphoplasty, a catheter is placed with a balloon into a collapsed vertebral body and is inflated slowly to expand the compressed vertebra to its normal height. The balloon kyphoplasty segment is witnessing a higher demand, and is expected to dominate as the procedure helps to restore vertebral disc height and relieves pain for a minimum of two years.

Request for Table of Content

Globally, vertebral compression fractures constitute a major proportion of health and economic burden; thus, effective VCF devices are necessary to treat compression fractures. VCF surgery is emerging as a significant treatment option, which makes use of VCF devices.

The increasing incidence of vertebral compression fractures has led to high adoption of the VCF devices. In addition, growth in geriatric population, rise in prevalence of lifestyle disorders (obesity), and advent of better VCF devices (balloon kyphoplasty, which helps to restore the disc height) drive the growth of VCF devices market globally.

Advanced spine surgery treatment options are a major driver for market growth. Currently, spine surgeons prefer minimal invasive surgical techniques for a wide range of VCF procedures, as lesser complications are associated with this procedure, such as reduced length of hospital stay and less bleeding.

Geographically, Asia-Pacific offers lucrative growth opportunities, especially emerging economies (such as China & India) for the market due to increase in healthcare expenditure, rise in geriatric population, and high incidence of spine impairments.